Join Annexon for an in-person and virtual key opinion leader (KOL) event to provide an overview of geographic atrophy (GA), an advanced form of dry, age-related macular degeneration (AMD) of the retina, featuring GA experts:

• Eleanora (Nora) Lad, MD, PhD – Vice Chair of Ophthalmology Clinical Research, Duke University Medical Center
• Charlie Wykoff, MD, PhD – Retina Specialist, Retina Consultants of Texas; Chair of Clinical Trials, Retina Consultants of America

Presentations from GA experts and Annexon will highlight:

• The unmet need and current treatment landscape for GA
• The mechanism of disease and role of C1q
• Vonaprument, Annexon’s neuroprotective C1q inhibitor with potential to be the first targeted vision-preserving therapy for GA
• Annexon’s pivotal Phase 3 ARCHER II trial expected to read out in the second half of this year

A live question and answer session will follow the formal presentations.